Royal Bank of Canada’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-16
| Closed | – | – | 7189 |
|
|
2022
Q4 | $0 | Sell |
16
-170
| -91% | – | ﹤0.01% | 7463 |
|
|
2022
Q3 | $1K | Buy |
+186
| New | +$1K | ﹤0.01% | 6871 |
|
|
2020
Q2 | – | Sell |
-500
| Closed | -$2K | – | 6439 |
|
|
2020
Q1 | $2K | Sell |
500
-45
| -8% | -$180 | ﹤0.01% | 5856 |
|
|
2019
Q4 | $3K | Hold |
545
| – | – | ﹤0.01% | 5905 |
|
|
2019
Q3 | $7K | Hold |
545
| – | – | ﹤0.01% | 5285 |
|
|
2019
Q2 | $8K | Sell |
545
-1
| -0.2% | -$15 | ﹤0.01% | 5262 |
|
|
2019
Q1 | $23K | Sell |
546
-17
| -3% | -$716 | ﹤0.01% | 4846 |
|
|
2018
Q4 | $24K | Sell |
563
-64
| -10% | -$2.73K | ﹤0.01% | 4789 |
|
|
2018
Q3 | $30K | Buy |
627
+78
| +14% | +$3.73K | ﹤0.01% | 4881 |
|
|
2018
Q2 | $26K | Buy |
549
+4
| +0.7% | +$189 | ﹤0.01% | 4855 |
|
|
2018
Q1 | $34K | Sell |
545
-7
| -1% | -$437 | ﹤0.01% | 4632 |
|
|
2017
Q4 | $29K | Buy |
552
+507
| +1,127% | +$26.6K | ﹤0.01% | 4691 |
|
|
2017
Q3 | $3K | Hold |
45
| – | – | ﹤0.01% | 5766 |
|
|
2017
Q2 | $2K | Buy |
+45
| New | +$2K | ﹤0.01% | 5554 |
|